| Vijay Ganatra, M.d., P.a. | |
|
13770 Plantation Rd Unit 4 Fort Myers FL 33912-4460 | |
| (239) 561-6263 | |
| (239) 561-6264 |
| Full Name | Vijay Ganatra, M.d., P.a. |
|---|---|
| Speciality | Internal Medicine |
| Location | 13770 Plantation Rd, Fort Myers, Florida |
| Authorized Official Name and Position | Vijay D Ganatra (PRESIDENT) |
| Authorized Official Contact | 2395616263 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Vijay Ganatra, M.d., P.a. 13770 Plantation Rd Ste 4 Fort Myers FL 33912-4460 Ph: (239) 561-6263 | Vijay Ganatra, M.d., P.a. 13770 Plantation Rd Unit 4 Fort Myers FL 33912-4460 Ph: (239) 561-6263 |
| NPI Number | 1053434258 |
|---|---|
| Provider Enumeration Date | 04/10/2007 |
| Last Update Date | 06/04/2018 |
| Medicare PECOS PAC ID | 4880727866 |
|---|---|
| Medicare Enrollment ID | O20100727000941 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053434258 | NPI | - | NPPES |
| 263735900 | Medicaid | FL | |
| DQ5776 | Other | FL | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME84201 (Florida) | Primary |
| Provider Name | Hesham Hassan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346256419 PECOS PAC ID: 4981640299 Enrollment ID: I20050707000858 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Tanzeen Ahmed |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437140480 PECOS PAC ID: 2567479512 Enrollment ID: I20060316000029 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Mark Norleans |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841211208 PECOS PAC ID: 1153320601 Enrollment ID: I20061211000051 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Shaheen Faruque |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386744639 PECOS PAC ID: 2264422989 Enrollment ID: I20070625000690 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | William Richard Porter |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1073569141 PECOS PAC ID: 4082670740 Enrollment ID: I20090224000380 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Shapour Steve Mirmanesh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669407375 PECOS PAC ID: 4789661802 Enrollment ID: I20100512001008 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Vijay D Ganatra |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215992144 PECOS PAC ID: 0547393522 Enrollment ID: I20100727001070 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Allen T Jacobs |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1467410464 PECOS PAC ID: 5799819314 Enrollment ID: I20100818000951 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Luis A Aponte |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790818607 PECOS PAC ID: 7315047180 Enrollment ID: I20100920000991 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Archana R Mandala |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1235320615 PECOS PAC ID: 2961690102 Enrollment ID: I20110103000681 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Oscar H Rodriguez Siguenas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1275723991 PECOS PAC ID: 7810084274 Enrollment ID: I20110627000639 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Pedro L Llera |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1215160262 PECOS PAC ID: 3971752726 Enrollment ID: I20121011000268 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Munish Bhalla |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851328363 PECOS PAC ID: 3971509464 Enrollment ID: I20130218000171 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Rachel Steinke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679912596 PECOS PAC ID: 3072754407 Enrollment ID: I20130729000308 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Denise M Schoonover |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215283783 PECOS PAC ID: 0345481339 Enrollment ID: I20130802000719 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Jose M Vazquez-cimadevilla |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1366600496 PECOS PAC ID: 4082864996 Enrollment ID: I20140925002429 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Cindy Zughbi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033400353 PECOS PAC ID: 5698995801 Enrollment ID: I20141009001275 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Charmy Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114214715 PECOS PAC ID: 8426279787 Enrollment ID: I20141030000531 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Christian M Morales |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992253959 PECOS PAC ID: 4880978311 Enrollment ID: I20170301001723 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Carmalee M Martin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003396714 PECOS PAC ID: 6507100385 Enrollment ID: I20181205001422 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Gerdie Jean-smith |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1346669025 PECOS PAC ID: 0143535369 Enrollment ID: I20190218002663 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Yamilka Suarez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760946255 PECOS PAC ID: 3678802592 Enrollment ID: I20190903000022 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Donatela Rodriguez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710540745 PECOS PAC ID: 0648502534 Enrollment ID: I20191025001062 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
| Provider Name | Yanan Wheeler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285208702 PECOS PAC ID: 3870995095 Enrollment ID: I20210712000607 |
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
News Archive
Exact Sciences today presented data showing that its non-invasive Cologuard stool-based (sDNA) screening test detected 64 percent of colorectal pre-cancers and 85 percent of cancers. The study was conducted in collaboration with Mayo Clinic and examined more than 1,100 patient samples. Results were presented at the 2010 Special Conference for Colorectal Cancer: Biology to Therapy held by the American Association for Cancer Research in Philadelphia, PA.
The Pennsylvania Patient Safety Authority supports "International Infection Prevention Week," October 18-24, 2009, to raise awareness of the need to protect patients and the public from healthcare-associated infections (HAIs).
A pair of studies by a team of scientists has shed new light on the nature of a particular type of DNA sequences—tandem DNA repeat arrays—that play important roles in transcription control, genome organization, and development.
Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
› Verified 1 days ago
Tele-id Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14192 Metropolis Ave, Fort Myers, FL 33912 Phone: 239-245-8223 Fax: 239-244-9481 | |
Vg Primary Care Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5285 Summerlin Rd Ste 101, Fort Myers, FL 33919 Phone: 978-495-0389 | |
Millennium Physician Group Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13813 Metro Pkwy, Fort Myers, FL 33912 Phone: 855-674-4624 | |
Lch- Peds Page Field Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4751 S Cleveland Ave, Fort Myers, FL 33907 Phone: 239-343-9888 Fax: 239-343-9968 | |
Lch-internal Medicine Matthew Drive Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1569 Matthew Dr, Fort Myers, FL 33907 Phone: 239-343-8220 Fax: 239-468-7909 | |
G & C Medical Center Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4048 Evans Ave, Suite 208, Fort Myers, FL 33901 Phone: 786-991-4400 | |
Millennium Physician Group Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9671 Gladiolus Dr Ste 109, Fort Myers, FL 33908 Phone: 239-362-1450 Fax: 239-985-9629 |